Publication | Closed Access

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

Treatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyVirologyRitonavir-boosted DarunavirPharmacotherapyNon-inferiority TrialAntiviral DrugHivMedicineViral ImmunityWeek Results